tradingkey.logo
tradingkey.logo
Search

ICON PLC

ICLR
Add to Watchlist
163.565USD
-1.965-1.19%
Close 07-31 16:00ETQuotes delayed by 15 min
12.62BMarket Cap
21.91P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.19%

5 Days

-1.32%

1 Month

-5.84%

6 Months

-9.26%

Year to Date

-10.24%

1 Year

-3.32%

Key Figures
165.450Open
171.740High
871.92KVolume
21.91P/E TTM
14.72P/E Dynamic
--Dividend TTM
1.13%Turnover Ratio
165.530Prev. Close
162.405Low
92.96MTurnover
15.94P/E Static
1.35P/B
0.00%Div Yield TTM
3.56%ROA
211.00052wk High
0.65Volume Ratio
791.47MNet Profit
77.15MShares
7.4645EPS TTM
1.26Beta
6.27%ROE
66.57052wk Low
5.64%Amplitude
18.83%Gross Margin
12.62BMarket Cap
-1.39Reward/Risk
3.14%Risk Rate

TradingKey Stock Score of ICON PLC

Currency: USD Updated: 2026-07-31

Key Insights

ICON PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 187.27.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

ICON PLC's Score

Industry at a Glance

Industry Ranking
58 / 385
Overall Ranking
132 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive+

ICON PLC Highlights

StrengthsRisks
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 8.25B.
Fairly Valued
The company’s latest PE is 21.91, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 83.08M shares, decreasing 15.66% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 2.80M shares of this stock.

Analyst Rating

Based on 18 analysts
Buy
Current Rating
187.267
Target Price
+5.10%
Upside Space

ICON PLC News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 18 analysts
Buy
Current Rating
187.267
Target Price
+5.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
ICON PLC
ICLR
18
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-2.834
Neutral
RSI(14)
48.607
Neutral
STOCH(KDJ)(9,3,3)
23.685
Sell
ATR(14)
8.686
High Vlolatility
CCI(14)
-73.715
Neutral
Williams %R
91.024
Oversold
TRIX(12,20)
0.344
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
171.259
Sell
MA10
169.245
Sell
MA20
169.011
Sell
MA50
154.961
Buy
MA100
132.443
Buy
MA200
148.254
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

ICON PLC Info

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Ticker SymbolICLR
CompanyICON PLC
CEOBalfe (Barry Edward)
Websitehttps://www.iconplc.com/

Shareholders

Shareholders
Shareholders
Proportion
Artisan Partners Limited Partnership
10.84%
Wellington Management Company, LLP
5.70%
Orbis Investment Management Ltd.
5.52%
Principal Global Investors (Equity)
4.34%
Invesco Advisers, Inc.
4.31%
Other
69.29%

FAQs

What is the current price of ICON PLC (ICLR)?

The current price of ICON PLC (ICLR) is 163.24.

What is the symbol of ICON PLC?

The ticker symbol of ICON PLC is ICLR.

What is the 52-week high of ICON PLC?

The 52-week high of ICON PLC is 211.00.

What is the 52-week low of ICON PLC?

The 52-week low of ICON PLC is 66.57.

What is the market capitalization of ICON PLC?

The market capitalization of ICON PLC is 12.59B.

Is ICON PLC (ICLR) currently rated as Buy, Hold, or Sell?

According to analysts, ICON PLC (ICLR) has an overall rating of Buy, with a price target of 187.27.

What is the Earnings Per Share (EPS TTM) of ICON PLC (ICLR)?

The Earnings Per Share (EPS TTM) of ICON PLC (ICLR) is 2.92.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.